A. Zafar, N. Esteghamat, H. AbdulHaq, P. Kaesberg, R. Hoeg, A. Tsumara, S. Chen, S. Li, B. Heyman, P. Young, M. Bukari, C. Mulroney, H. Eradat, A. S. Rosenberg, J. Tuscano. A UC HEMATOLOGIC MALIGNANCY CONSORTIUM PHASE II TRIAL OF OBINUTUZUMAB, IBRUTINIB AND VENETOCLAX IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA. Hematological Oncology. 2025 Jun 16; 43(S3).